EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The role of lysophosphatidic acid metabolism in castration-resistant prostate cancer progression

Jinpeng Feng, Jiale Liu, Yi He

Frontiers in Oncology · 22.05.2026 · 16

DOI: 10.3389/fonc.2026.1842091 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 22.05.2026. Verfasst von Jinpeng Feng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Jiaxing University Master Degree Cultivation Base, Zhejiang Chinese Medical University, Hangzhou, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PCa) is a leading malignancy in men, with mortality primarily attributed to progression to castration-resistant prostate cancer (CRPC). Although androgen deprivation therapy (ADT) initially demonstrates efficacy, most advanced patients eventually develop CRPC—a stage characterized by limited treatment options and poor prognosis. Elucidating the molecular mechanisms underlying CRPC transformation therefore represents a research priority. Tumor metabolic reprogramming has emerged as a hallmark of cancer, and among various metabolic pathways, lysophosphatidic acid (LPA)—a bioactive lipid mediator—has been increasingly implicated in PCa progression, particularly CRPC transformation. This review systematically examines LPA metabolic sources and signal transduction mechanisms and explores how LPA promotes CRPC progression through driving proliferation, survival, invasion, therapy resistance, and tumor microenvironment remodeling. Finally, we discuss the potential and challenges of targeting the LPA signaling pathway as a novel therapeutic strategy for CRPC.

Schlagwörter

Stichwörter der Autor:innen

castration resistancelysophosphatidic acidmetabolic reprogrammingprostate cancertargeted therapy

Autor:innen und Institutionen

  • Jiaxing University Master Degree Cultivation Base, Zhejiang Chinese Medical University, Hangzhou, China.
  • Department of Urology, The Afffliated Hospital of Jiaxing University, Jiaxing, China.

Zitieren

APA

Feng, J., Liu, J., & He, Y. (2026). The role of lysophosphatidic acid metabolism in castration-resistant prostate cancer progression. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1842091

Vancouver

Feng J, Liu J, He Y. The role of lysophosphatidic acid metabolism in castration-resistant prostate cancer progression. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1842091

BibTeX
@article{Feng2026,
  author = {Feng, Jinpeng and Liu, Jiale and He, Yi},
  title = {The role of lysophosphatidic acid metabolism in castration-resistant prostate cancer progression},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1842091}
}
Kostenlos starten →